Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development

Modern Pathology

Volumn 26, Issue 1, 2013, Pages 10-21

  Alarmo, Emma Leena ^a,b   Huhtala, Heini ^a   Korhonen, Tarja ^c   Pylkkänen, Liisa ^a,d   Holli, Kaija ^a   Kuukasjärvi, Tuula ^c   Parkkila, Seppo ^a,b   Kallioniemi, Anne ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b FIMLAB LABORATORIES   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Bone morphogenetic protein 4; breast cancer; cancer; immunohistochemistry; normal tissue; protein expression; tissue microarray

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4;

ARTICLE; BLADDER EPITHELIUM; BREAST CANCER; BREAST CARCINOMA; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STOMACH EPITHELIUM; TUMOR RECURRENCE;

ADULT; BONE MORPHOGENETIC PROTEIN 4; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84871925853     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.128     Document Type: Article

References (52)

1. Miyazono K, Kamiya Y, Morikawa M. Bone morphogeneticprotein receptors and signal transduction.J Biochem 2012;147:35-51
2. Reddi AH. Bone morphogenetic proteins: an unconventionalapproach to isolation of first mammalianmorphogens. Cytokine Growth Factor Rev 1997;8:11-20 (Pubitemid 27214686)
3. Zhao GQ. Consequences of knocking out BMP signalingin the mouse. Genesis 2003;35:43-56
4. Winnier G, Blessing M, Labosky PA, et al. Bonemorphogenetic protein-4 is required for mesodermformation and patterning in the mouse. Genes Dev1995;9:2105-2116
5. Danesh SM, Villasenor A, Chong D, et al. BMP andBMP receptor expression during murine organogenesis.Gene Expr Patterns 2009;9:255-265
6. Hogan BL. Bone morphogenetic proteins: multifunctionalregulators of vertebrate development. Genes Dev1996;10:1580-1594 (Pubitemid 26268864)
7. Robinson GW. Cooperation of signalling pathwaysin embryonic mammary gland development. Nat RevGenet 2007;8:963-972 (Pubitemid 350129174)
8. Schmierer B, Hill CS. TGFbeta-SMAD signal transduction:molecular specificity and functional flexibility.Nat Rev Mol Cell Biol 2007;8:970-982 (Pubitemid 350174642)
9. Sieber C, Kopf J, Hiepen C, et al. Recent advances inBMP receptor signaling. Cytokine Growth Factor Rev2009;20:343-355
10. Bragdon B, Moseychuk O, Saldanha S, et al. Bonemorphogenetic proteins: a critical review. Cell Signal2011;23:609-620
11. Nakase T, Yoshikawa H. Potential roles of bonemorphogenetic proteins (BMPs) in skeletal repair andregeneration. J Bone Miner Metab 2006;24:425-433 (Pubitemid 44663413)
12. Otsuka F. Multiple endocrine regulation by bonemorphogenetic protein system. Endocr J 2010;57:3-14
13. Goulley J, Dahl U, Baeza N, et al. BMP4-BMPR1Asignaling in beta cells is required for and augmentsglucose-stimulated insulin secretion. Cell Metab2007;5:207-219
14. Paulson RF, Shi L, Wu DC. Stress erythropoiesis: newsignals and new stress progenitor cells. Curr OpinHematol 2011;18:139-145
15. Myllarniemi M, Vuorinen K, Pulkkinen V, et al.Gremlin localization and expression levels partiallydifferentiate idiopathic interstitial pneumonia severityand subtype. J Pathol 2008;214:456-463 (Pubitemid 351340565)
16. Badreddine RJ, Wang KK. Barrett esophagus: an update.Nat Rev Gastroenterol Hepatol 2010;7:369-378
17. Singh A, Morris RJ. The yin and yang of bonemorphogenetic proteins in cancer. Cytokine GrowthFactor Rev 2010;21:299-313
18. Buckley S, Shi W, Driscoll B, et al. BMP4 signalinginduces senescence and modulates the oncogenicphenotype of A549 lung adenocarcinoma cells. Am JPhysiol Lung Cell Mol Physiol 2004;286:L81-L86 (Pubitemid 38055861)
19. Rothhammer T, Poser I, Soncin F, et al. Bonemorphogenic proteins are overexpressed in malignantmelanoma and promote cell invasion and migration.Cancer Res 2005;65:448-456
20. Deng H, Makizumi R, Ravikumar TS, et al. Bonemorphogenetic protein-4 is overexpressed in colonicadenocarcinomas and promotes migration and invasionof HCT116 cells. Exp Cell Res 2007;313:1033-1044 (Pubitemid 46273448)
21. Hamada S, Satoh K, Hirota M, et al. Bone morphogeneticprotein 4 induces epithelial-mesenchymaltransition through MSX2 induction on pancreaticcancer cell line. J Cell Physiol 2007;213:768-774 (Pubitemid 350058270)
22. Theriault BL, Shepherd TG, Mujoomdar ML, et al.BMP4 induces EMT and rho GTPase activation inhuman ovarian cancer cells. Carcinogenesis 2007;28:1153-1162 (Pubitemid 47062673)
23. Ketolainen JM, Alarmo EL, Tuominen VJ, et al. Parallelinhibition of cell growth and induction of cellmigration and invasion in breast cancer cells by bonemorphogenetic protein 4. Breast Cancer Res Treat2010;124:377-386
24. Wahdan-Alaswad RS, Song K, Krebs TL, et al. Insulinlikegrowth factor I suppresses bone morphogeneticprotein signaling in prostate cancer cells by activatingmTOR signaling. Cancer Res 2010;70:9106-9117
25. Virtanen S, Alarmo EL, Sandstrom S, et al. Bonemorphogenetic protein-4 and-5 in pancreatic cancer-novel bidirectional players. Exp Cell Res 2011;317:2136-2146
26. Houlston RS, Webb E, Broderick P, et al. Meta-analysisof genome-wide association data identifies four newsusceptibility loci for colorectal cancer. Nat Genet2008;40:1426-1435
27. Kwak C, Park YH, Kim IY, et al. Expression of bonemorphogenetic proteins, the subfamily of the transforminggrowth factor-beta superfamily, in renal cellcarcinoma. J Urol 2007;178:1062-1067
28. Kim SG, Park HR, Min SK, et al. Expression of bonemorphogenic protein-4 is inversely related to prevalenceof lymph node metastasis in gastric adenocarcinoma.Surg Today 2011;41:688-692
29. Laatio L, Myllynen P, Serpi R, et al. BMP-4 expressionhas prognostic significance in advanced serous ovariancarcinoma and is affected by cisplatin in OVCAR-3cells. Tumour Biol 2011;32:985-995
30. Xu T, Yu CY, Sun JJ, et al. Bone morphogenetic protein-4-induced epithelial-mesenchymal transition andinvasiveness through Smad1-mediated signal pathwayin squamous cell carcinoma of the head and neck.Arch Med Res 2011;42:128-137
31. Chiu CY, Kuo KK, Kuo TL, et al. The activation ofMEK/ERK signaling pathway by bone morphogeneticprotein 4 to increase hepatocellular carcinoma cellproliferation and migration. Mol Cancer Res 2012;10:415-427
32. Alarmo EL, Kallioniemi A. Bone morphogeneticproteins in breast cancer: Dual role in tumourigenesis?Endocr Relat Cancer 2010;17:R123-R139
33. Alarmo EL, Kuukasjarvi T, Karhu R, et al. A comprehensiveexpression survey of bone morphogeneticproteins in breast cancer highlights the importance ofBMP4 and BMP7. Breast Cancer Res Treat 2007;103:239-246 (Pubitemid 46789146)
34. Korhonen T, Huhtala H, Holli K. A comparison of thebiological and clinical features of invasive lobular andductal carcinomas of the breast. Breast Cancer ResTreat 2004;85:23-29 (Pubitemid 38437980)
35. Alarmo EL, Korhonen T, Kuukasjarvi T, et al. Bonemorphogenetic protein 7 expression associates withbone metastasis in breast carcinomas. Ann Oncol2008;19:308-314 (Pubitemid 351201712)
36. Kelleher FC, Fennelly D, Rafferty M. Common criticalpathways in embryogenesis and cancer. Acta Oncol2006;45:375-388
37. Thawani JP, Wang AC, Than KD, et al. Bone morphogeneticproteins and cancer: review of the literature.Neurosurgery 2010;66:233-246
38. Milano F, van Baal JW, Buttar NS, et al. Bonemorphogenetic protein 4 expressed in esophagitisinduces a columnar phenotype in esophageal squamouscells. Gastroenterology 2007;132:2412-2421 (Pubitemid 46890856)
39. Bleuming SA, Kodach LL, Garcia Leon MJ, et al. Alteredbonemorphogenetic protein signalling in the helicobacterpylori-infected stomach. J Pathol 2006;209:190-197 (Pubitemid 43805414)
40. van Baal JW, Milana F, Rygiel AM, et al. A comparativeanalysis by SAGE of gene expression profiles ofesophageal adenocarcinoma and esophageal squamouscell carcinoma. Cell Oncol 2008;30:63-75 (Pubitemid 351161034)
41. Strnad H, Lacina L, Kolar M, et al. Head and necksquamous cancer stromal fibroblasts produce growthfactors influencing phenotype of normal humankeratinocytes. Histochem Cell Biol 2010;133:201-211
42. Guo X, Xiong L, Zou L, et al. Upregulation of bonemorphogenetic protein 4 is associated with poorprognosis in patients with hepatocellular carcinoma.Pathol Oncol Res 2012;18:635-640
43. Langenfeld EM, Bojnowski J, Perone J, et al. Expressionof bone morphogenetic proteins in human lungcarcinomas. Ann Thorac Surg 2005;80:1028-1032 (Pubitemid 41196808)
44. Bieniasz M, Oszajca K, Eusebio M, et al. The positivecorrelation between gene expression of the twoangiogenic factors: VEGF and BMP-2 in lung cancerpatients. Lung Cancer 2009;66:319-326
45. Bentley H, Hamdy FC, Hart KA, et al. Expression ofbone morphogenetic proteins in human prostaticadenocarcinoma and benign prostatic hyperplasia.Br J Cancer 1992;66:1159-1163 (Pubitemid 23006160)
46. Piccirillo SG, Reynolds BA, Zanetti N, et al. Bonemorphogenetic proteins inhibit the tumorigenicpotential of human brain tumour-initiating cells.Nature 2006;444:761-765 (Pubitemid 44949605)
47. Maegdefrau U, Amann T, Winklmeier A, et al. Bonemorphogenetic protein 4 is induced in hepatocellularcarcinoma by hypoxia and promotes tumour progression.J Pathol 2009;218:520-529
48. Montesano R. Bone morphogenetic protein-4 abrogateslumen formation by mammary epithelial cellsand promotes invasive growth. Biochem Biophys ResCommun 2007;353:817-822 (Pubitemid 46048745)
49. Montesano R, Sarkozi R, Schramek H. Bone morphogeneticprotein-4 strongly potentiates growth factorinducedproliferation of mammary epithelial cells.Biochem Biophys Res Commun 2008;374:164-168
50. Hartmann O, Spyratos F, Harbeck N, et al. DNAmethylation markers predict outcome in nodepositive,estrogen receptor-positive breast cancer withadjuvant anthracycline-based chemotherapy. ClinCancer Res 2009;15:315-323
51. Siegel PM, Massague J. Cytostatic and apoptoticactions of TGF-beta in homeostasis and cancer. NatRev Cancer 2003;3:807-821
52. Massague J, Gomis RR. The logic of TGFbeta signaling.FEBS Lett 2006;580:2811-2820